Type 1 IFN inhibits the growth factor deprived apoptosis of cultured human aortic endothelial cells and protects the cells from chemically induced oxidative cytotoxicity

Emiko Sano, Shinnya Tashiro, Hisashi Tadakuma, Toshiaki Takei, Takuya Ueda, Kouhei Tsumoto

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

It has been shown that the genesis of atherosclerotic lesions is resulted from the injury of vascular endothelial cells and the cell damage is triggered by oxygen radicals generated from various tissues. Human vascular endothelial cells can survive and proliferate depending on growth factors such as VEGF or basic FGF and are induced apoptosis by the deprivation of growth factor or serum. It was found that type 1 IFN inhibits the growth factor deprived cell death of human aortic endothelial cells (HAEC) and protects the cells from chemically induced oxidative cytotoxicity. The anti-apoptotic effects of type 1 IFN were certified by flow cytometry using annexin-V-FITC/PI double staining and cell cycle analysis, fluorescence microscopy using Hoechst33342 and PI, colorimetric assay for caspase-3 activity, p53 and bax mRNA expressions, and cell counts. It was considered that IFN-β inhibits the executive late stage apoptosis from the results of annexin-V-FITC/PI double staining and the inhibition of caspase-3 activity, and that the anti-apoptotic effect might be owing to the direct inhibition of the apoptotic pathway mediated by p53 from the transient down-regulation of bax mRNA expression. Whereas, type 1 IFN protected the cells from the oxidative cytotoxicity induced by tertiary butylhydroperoxide (TBH) under the presence of Ca2+. The effects of IFN-β is more potent inhibitor of cell death than IFN-α. These results indicate that type 1 IFN, especially IFN-β may be useful for the diseases with vascular endothelium damage such as atherosclerosis or restenosis after angioplasty as a medical treatment or a prophylactic.

Original languageEnglish
Pages (from-to)3823-3834
Number of pages12
JournalJournal of Cellular Biochemistry
Volume113
Issue number12
DOIs
Publication statusPublished - 2012 Dec 1
Externally publishedYes

Fingerprint

Endothelial cells
Cytotoxicity
Intercellular Signaling Peptides and Proteins
Endothelial Cells
Fluorescein-5-isothiocyanate
Annexin A5
Cell death
Apoptosis
Caspase 3
Cell Death
Cells
Staining and Labeling
tert-Butylhydroperoxide
Messenger RNA
Flow cytometry
Fluorescence microscopy
Vascular Endothelium
Angioplasty
Fluorescence Microscopy
Vascular Endothelial Growth Factor A

Keywords

  • ANTI-APOPTOTIC EFFECT
  • GROWTH FACTOR DEPRIVATION
  • HUMAN ENDOTHELIAL CELLS
  • TERTIARY BUTYLHYDROPEROXIDE
  • TYPE 1 IFN

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Type 1 IFN inhibits the growth factor deprived apoptosis of cultured human aortic endothelial cells and protects the cells from chemically induced oxidative cytotoxicity. / Sano, Emiko; Tashiro, Shinnya; Tadakuma, Hisashi; Takei, Toshiaki; Ueda, Takuya; Tsumoto, Kouhei.

In: Journal of Cellular Biochemistry, Vol. 113, No. 12, 01.12.2012, p. 3823-3834.

Research output: Contribution to journalArticle

@article{677089b090464aa1980c6cc0144224ee,
title = "Type 1 IFN inhibits the growth factor deprived apoptosis of cultured human aortic endothelial cells and protects the cells from chemically induced oxidative cytotoxicity",
abstract = "It has been shown that the genesis of atherosclerotic lesions is resulted from the injury of vascular endothelial cells and the cell damage is triggered by oxygen radicals generated from various tissues. Human vascular endothelial cells can survive and proliferate depending on growth factors such as VEGF or basic FGF and are induced apoptosis by the deprivation of growth factor or serum. It was found that type 1 IFN inhibits the growth factor deprived cell death of human aortic endothelial cells (HAEC) and protects the cells from chemically induced oxidative cytotoxicity. The anti-apoptotic effects of type 1 IFN were certified by flow cytometry using annexin-V-FITC/PI double staining and cell cycle analysis, fluorescence microscopy using Hoechst33342 and PI, colorimetric assay for caspase-3 activity, p53 and bax mRNA expressions, and cell counts. It was considered that IFN-β inhibits the executive late stage apoptosis from the results of annexin-V-FITC/PI double staining and the inhibition of caspase-3 activity, and that the anti-apoptotic effect might be owing to the direct inhibition of the apoptotic pathway mediated by p53 from the transient down-regulation of bax mRNA expression. Whereas, type 1 IFN protected the cells from the oxidative cytotoxicity induced by tertiary butylhydroperoxide (TBH) under the presence of Ca2+. The effects of IFN-β is more potent inhibitor of cell death than IFN-α. These results indicate that type 1 IFN, especially IFN-β may be useful for the diseases with vascular endothelium damage such as atherosclerosis or restenosis after angioplasty as a medical treatment or a prophylactic.",
keywords = "ANTI-APOPTOTIC EFFECT, GROWTH FACTOR DEPRIVATION, HUMAN ENDOTHELIAL CELLS, TERTIARY BUTYLHYDROPEROXIDE, TYPE 1 IFN",
author = "Emiko Sano and Shinnya Tashiro and Hisashi Tadakuma and Toshiaki Takei and Takuya Ueda and Kouhei Tsumoto",
year = "2012",
month = "12",
day = "1",
doi = "10.1002/jcb.24259",
language = "English",
volume = "113",
pages = "3823--3834",
journal = "Journal of Cellular Biochemistry",
issn = "0730-2312",
publisher = "Wiley-Liss Inc.",
number = "12",

}

TY - JOUR

T1 - Type 1 IFN inhibits the growth factor deprived apoptosis of cultured human aortic endothelial cells and protects the cells from chemically induced oxidative cytotoxicity

AU - Sano, Emiko

AU - Tashiro, Shinnya

AU - Tadakuma, Hisashi

AU - Takei, Toshiaki

AU - Ueda, Takuya

AU - Tsumoto, Kouhei

PY - 2012/12/1

Y1 - 2012/12/1

N2 - It has been shown that the genesis of atherosclerotic lesions is resulted from the injury of vascular endothelial cells and the cell damage is triggered by oxygen radicals generated from various tissues. Human vascular endothelial cells can survive and proliferate depending on growth factors such as VEGF or basic FGF and are induced apoptosis by the deprivation of growth factor or serum. It was found that type 1 IFN inhibits the growth factor deprived cell death of human aortic endothelial cells (HAEC) and protects the cells from chemically induced oxidative cytotoxicity. The anti-apoptotic effects of type 1 IFN were certified by flow cytometry using annexin-V-FITC/PI double staining and cell cycle analysis, fluorescence microscopy using Hoechst33342 and PI, colorimetric assay for caspase-3 activity, p53 and bax mRNA expressions, and cell counts. It was considered that IFN-β inhibits the executive late stage apoptosis from the results of annexin-V-FITC/PI double staining and the inhibition of caspase-3 activity, and that the anti-apoptotic effect might be owing to the direct inhibition of the apoptotic pathway mediated by p53 from the transient down-regulation of bax mRNA expression. Whereas, type 1 IFN protected the cells from the oxidative cytotoxicity induced by tertiary butylhydroperoxide (TBH) under the presence of Ca2+. The effects of IFN-β is more potent inhibitor of cell death than IFN-α. These results indicate that type 1 IFN, especially IFN-β may be useful for the diseases with vascular endothelium damage such as atherosclerosis or restenosis after angioplasty as a medical treatment or a prophylactic.

AB - It has been shown that the genesis of atherosclerotic lesions is resulted from the injury of vascular endothelial cells and the cell damage is triggered by oxygen radicals generated from various tissues. Human vascular endothelial cells can survive and proliferate depending on growth factors such as VEGF or basic FGF and are induced apoptosis by the deprivation of growth factor or serum. It was found that type 1 IFN inhibits the growth factor deprived cell death of human aortic endothelial cells (HAEC) and protects the cells from chemically induced oxidative cytotoxicity. The anti-apoptotic effects of type 1 IFN were certified by flow cytometry using annexin-V-FITC/PI double staining and cell cycle analysis, fluorescence microscopy using Hoechst33342 and PI, colorimetric assay for caspase-3 activity, p53 and bax mRNA expressions, and cell counts. It was considered that IFN-β inhibits the executive late stage apoptosis from the results of annexin-V-FITC/PI double staining and the inhibition of caspase-3 activity, and that the anti-apoptotic effect might be owing to the direct inhibition of the apoptotic pathway mediated by p53 from the transient down-regulation of bax mRNA expression. Whereas, type 1 IFN protected the cells from the oxidative cytotoxicity induced by tertiary butylhydroperoxide (TBH) under the presence of Ca2+. The effects of IFN-β is more potent inhibitor of cell death than IFN-α. These results indicate that type 1 IFN, especially IFN-β may be useful for the diseases with vascular endothelium damage such as atherosclerosis or restenosis after angioplasty as a medical treatment or a prophylactic.

KW - ANTI-APOPTOTIC EFFECT

KW - GROWTH FACTOR DEPRIVATION

KW - HUMAN ENDOTHELIAL CELLS

KW - TERTIARY BUTYLHYDROPEROXIDE

KW - TYPE 1 IFN

UR - http://www.scopus.com/inward/record.url?scp=84867530142&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867530142&partnerID=8YFLogxK

U2 - 10.1002/jcb.24259

DO - 10.1002/jcb.24259

M3 - Article

VL - 113

SP - 3823

EP - 3834

JO - Journal of Cellular Biochemistry

JF - Journal of Cellular Biochemistry

SN - 0730-2312

IS - 12

ER -